INGN
NASDAQ HealthcareInogen, Inc - Common Stock
Medical Devices
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
๐ Market Data
| Price | $6.98 |
|---|---|
| Volume | 175,473 |
| Market Cap | 190.73M |
| Beta | 1.710 |
| RSI (14-Day) | 61.5 |
| 200-Day MA | $7.03 |
| 50-Day MA | $6.44 |
| 52-Week High | $9.13 |
| 52-Week Low | $5.34 |
| Forward P/E | -22.52 |
| Price / Book | 0.99 |
๐ฏ Investment Strategy Scores
INGN scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (82/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Institutional Whale (3/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find INGN in your text
Paste any article, transcript, or post โ the tool will extract INGN and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.